Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest Roche Diagnostics Stories

2012-06-07 10:23:32

INDIANAPOLIS, June 7, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has filed a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a fully automated TnT-hs assay for use on Roche's full portfolio of laboratory analyzers.* Intended as an aid in the in the diagnosis of myocardial infarction, the electrochemiluminescence (ECL) immunoassay is used for the in vitro quantitative determination of TnT-hs in human serum and plasma. Roche...

2012-06-05 02:28:51

INDIANAPOLIS, June 5, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the establishment of a strategic alliance with med fusion LLC in Lewisville, Texas, that designates the company as a Roche Molecular Center of Excellence (MCOE) for the next five years. As a nationally recognized Roche MCOE, med fusion's molecular diagnostics laboratory will offer physicians and patients some of the latest and most advanced molecular technologies, such as Roche's cobas® 4800...

2012-05-30 02:24:08

PALO ALTO, Calif. and INDIANAPOLIS, May 30, 2012 /PRNewswire/ -- Glooko, Inc., makers of an innovative diabetes logbook solution, and Roche Diabetes Care, makers of ACCU-CHEK blood glucose monitoring systems, insulin pumps and information management solutions, today announced their co-promotion of the Glooko Logbook solution in the U.S. With the introduction of the Glooko IR Adapter, ACCU-CHEK customers who prefer to manage their diabetes on their iPhone or iPod touch can now use the Glooko...

2012-05-15 02:29:27

BRANFORD, Connecticut and SHENZHEN, China, May 15, 2012 /PRNewswire/ -- BGI, one of the world's largest genomics organizations, announced today that a new Roche GS FLX+ System has been successfully installed at its facility in Shenzhen, China. The goal is to complement the existing array of short read sequencing technologies and enhance BGI's long read sequencing capability. The GS FLX+ System, developed by 454 Life Sciences, a Roche Company, features the unique...

2012-05-09 02:26:54

BRANFORD, Connecticut and STATE COLLEGE, Pennsylvania, May 9, 2012 /PRNewswire/ -- 454 Life Sciences, a Roche Company, and SoftGenetics announced today that the two firms have entered into a co-promotion agreement designed to provide users of 454 Sequencing Systems the broad range of next-generation sequencing data analysis options provided by SoftGenetics NextGENe(R) software. NextGENe(R) software is a free standing biologist-friendly software multi-package that is fully...

2012-04-24 02:29:55

BRANFORD, Connecticut, April 24, 2012 /PRNewswire/ -- Roche announced today the launch and immediate availability of the GS GType TET2/CBL/KRAS and the GS GType RUNX1 Primer Sets for comprehensive genetic variation detection in four key human genes using the company's 454 GS Junior [http://my454.com/products/gs-junior-system/index.asp ] and GS FLX Systems [http://www.454.com/products-solutions/product-list.asp ]. The sequence-based assays offer a new solution for cancer...

2012-04-16 02:28:14

BRANFORD, Connecticut, April 16, 2012 /PRNewswire/ -- Roche announced today the immediate availability of a new software upgrade and further upcoming sequencing performance and workflow improvements to the company's 454 GS Junior System. Now a widely published benchtop next-generation sequencing platform, the GS Junior System is rapidly advancing research worldwide in areas of infectious disease, cancer, environmental microbiology and agriculture[1]. The new software package...

2012-03-30 10:22:27

PLEASANTON, Calif., March 30, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the FDA approval of a new pre-analytical instrument that provides an integrated primary tube handling solution for its widely adopted automated molecular testing platform. The cobas p 630 Instrument, being introduced with new AMPLILINK 3.3 series software, unites primary tube handling with fully automated sample preparation, amplification and detection for molecular diagnostics on COBAS®...

2012-03-28 02:24:53

PENZBERG, Germany, March 28, 2012 /PRNewswire/ -- Roche's xCELLigence RTCA [https://www.roche-applied-science.com/sis/xcelligence/index.jsp?&id=xcect_000000 ] System is being used in the European Union's SEURAT (Safety Evaluation Ultimately Replacing Animal Testing) initiative to run five years from 2011 to 2016. As of 2013, animal experiments are no longer permitted for use in toxicology testing in the cosmetic industry. Significant progress has been made in recent years...

2012-03-15 05:00:00

PLEASANTON, Calif., March 15, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today welcomed new guidelines for the prevention and early detection of cervical cancer issued jointly by the American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP). For the first time, these professional organizations together issued guidelines that using human papillomavirus (HPV) testing in...